Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 3/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2407953 | 0.91 | — | — | |
| SCHEMBL26130340 | 0.89 | PGR (0.37) | PGRAPEX1CYP1A2CYP2C19KMT2A | |
| SCHEMBL2406646 | 0.87 | — | — | |
| SCHEMBL1286295 | 0.86 | APEX1 (0.41) | PGRAPEX1THRBTDP1PDK2 | |
| SCHEMBL2332113 | 0.83 | APEX1 (0.39) | PGRAPEX1CYP1A2CYP2C19KMT2A | |
| SCHEMBL29484836 | 0.82 | APEX1 (0.47) | PGRAPEX1THRBTDP1CYP1A2 | |
| SCHEMBL1394829 | 0.82 | APEX1 (0.47) | PGRAPEX1THRBTDP1CYP1A2 | |
| SCHEMBL1334440 | 0.81 | MMP2 (0.38) | PGRAPEX1TDP1CYP2C19KMT2A | |
| SCHEMBL1335312 | 0.81 | MMP2 (0.38) | PGRAPEX1TDP1CYP2C19KMT2A | |
| SCHEMBL2409026 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116997575-A | Polymer and application thereof | 日产化学株式会社 | 2023-11-03 | — | — | CN | disclosed |
| WO-2023189399-A1 | POLYMER AND USE THEREOF | 日産化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-9865823-B2 | Quinolinium dyes with fluorinated counter anion for dye sensitized solar cells | BASF SE (DE) | 2018-01-09 | — | — | US | disclosed |
| CN-104370801-B | Carbazole compound and application thereof | 东曹株式会社 | 2017-11-03 | — | — | CN | disclosed |
| US-9650565-B2 | Carbazole compound and use thereof | TOSOH CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| CN-104326968-B | Carbazole compound and use thereof | 东曹株式会社 | 2017-04-12 | — | — | CN | disclosed |
| EP-2772483-B1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | TOSOH CORP (JP) | 2017-03-29 | — | — | EP | disclosed |
| EP-2006278-B2 | BENZOFLUORENE COMPOUND AND USE THEREOF | TOSOH CORP (JP) | 2016-10-12 | — | — | EP | disclosed |
| CN-104011022-B | 4-aminocarbazole compound and application thereof | 东曹株式会社 | 2016-08-24 | — | — | CN | disclosed |
| US-20160155575-A1 | METHINE DYES WITH LARGE ORGANIC COUNTER ANION FOR DYE SENSITIZED SOLAR CELLS | BASF SE (DE) | 2016-06-02 | — | — | US | disclosed |
| CN-101421226-A | Benzofluorene compound and use thereof | TOSOH CORP (JP) | 2009-04-29 | — | — | CN | disclosed |
| US-7482490-B2 | Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound | TOSOH CORPORATION (JP) | 2009-01-27 | — | — | US | disclosed |
| EP-2006278-A2 | BENZOFLUORENE COMPOUND AND USE THEREOF | Tosoh Corporation (JP) | 2008-12-24 | — | — | EP | disclosed |
| US-20080194878-A1 | Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound | TOSOH CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-7189877-B2 | Arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | TOSCH CORPORATION (JP) | 2007-03-13 | — | — | US | disclosed |
| EP-1752440-A1 | AMINE COMPOUND HAVING FLUORENE GROUP AS FRAMEWORK, PROCESS FOR PRODUCING THE AMINE COMPOUND, AND USE OF THE AMINE COMPOUND | Tosoh Corporation (JP) | 2007-02-14 | — | — | EP | disclosed |
| EP-1400578-B1 | Electrolumisescent 9,9-bis(4-amino)-1,1'-biphenyl)fluorene derivatives | TOSOH CORP (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-20040110958-A1 | Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | TOSOH CORPORATION | 2004-06-10 | — | — | US | disclosed |
| EP-1400578-A1 | Electrolumisescent 9,9-bis(4-amino)-1,1'-biphenyl)fluorene derivatives | Tosoh Corporation (JP) | 2004-03-24 | — | — | EP | disclosed |
| CN-1374315-A | Metal complex, illuminated device and display equipment | KANON K K (JP) | 2002-10-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110958-A1 | Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | AHR, NAT1, AR | PGR 775/4885APEX1 753/4885THRB 741/4885 |
| US-20080194878-A1 | Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound | TAAR1, SLC18A1, ADRB2 | PGR 1021/4885APEX1 1887/4885THRB 765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.